WallStreetZenWallStreetZen

NASDAQ: INM
Inmed Pharmaceuticals Inc Stock Ownership - Who owns Inmed Pharmaceuticals?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Inmed Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Andrew HullDirector2024-02-2137,500$0.39
$14.63kBuy
Eric A. AdamsPresident CEO2024-02-2041,600$0.36
$14.93kBuy

1 of 1

INM insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when INM insiders and whales buy or sell their stock.

INM Shareholders

What type of owners hold Inmed Pharmaceuticals Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Shane Aaron Johnson9.63%583,023$146.92kInsider
Sabby Management LLC8.45%511,934$129.01kInstitution
Armistice Capital LLC3.40%205,968$51.90kInstitution
Eric A. Adams0.73%43,959$11.08kInsider
Renaissance Technologies LLC0.64%38,900$9.80kInstitution
Andrew Hull0.63%38,258$9.64kInsider
Citadel Advisors LLC0.56%34,009$8.57kInstitution
Two Sigma Securities LLC0.21%12,894$3.25kInstitution
Bruce Colwill0.19%11,515$2.90kInsider
Qube Research Technologies Ltd0.00%200$50.40Institution

1 of 3

INM vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
INM13.28%11.17%Net BuyingNet Buying
GRI6.80%86.05%
SPRC0.68%0.00%
ATNF7.45%92.55%Net Buying
VRAX7.37%0.00%
View Top Biotech Stocks

Inmed Pharmaceuticals Stock Ownership FAQ

Who owns Inmed Pharmaceuticals?

Inmed Pharmaceuticals (NASDAQ: INM) is owned by 13.28% institutional shareholders, 11.17% Inmed Pharmaceuticals insiders, and 75.55% retail investors. Shane Aaron Johnson is the largest individual Inmed Pharmaceuticals shareholder, owning 583,023.00 shares representing 9.63% of the company. Shane Aaron Johnson's Inmed Pharmaceuticals shares are currently valued at $134.10k.

If you're new to stock investing, here's how to buy Inmed Pharmaceuticals stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.